SCHEMBL6654380

SCHEMBL6654380

OCc1cc(Cl)ccc1Cc1nccn1Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.55
HSP90B1 P14625 2/20 0.44
HSP90AB1 P08238 1/20 0.44
MEN1 O00255 2/20 0.44
CYP3A4 P08684 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX12 P18054 1/20 0.44
CYP2C19 P33261 1/20 0.44
KCNH2 Q12809 1/20 0.41
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HIF1A Q16665 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NR3C1 P04150 1/20 0.40
AGTR1 P30556 1/20 0.39
AGTR2 P50052 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648269 0.80 KMT2A (0.46) KMT2AALDH1A1CYP2D6CYP2C19KCNH2
SCHEMBL2949433 0.80 SIGMAR1 (0.51) HSP90AA1MEN1CYP3A4KMT2AALDH1A1
SCHEMBL6650687 0.79 KMT2A (0.47) HSP90AA1MEN1CYP3A4KMT2AALDH1A1
SCHEMBL2872636 0.78 HSP90AA1 (0.60) HSP90AA1HSP90B1HSP90AB1MEN1CYP3A4
SCHEMBL6649429 0.77 KCNH2 (0.41) KCNH2
SCHEMBL6650163 0.77 PSEN1 (0.38) MEN1CYP3A4KMT2ACYP1A2CYP2D6
SCHEMBL11743169 0.76 MEN1 (0.48) HSP90AA1HSP90B1MEN1CYP3A4KMT2A
Hydrochloric Acid SCHEMBL10611283 0.76 HSP90AA1 (0.58) HSP90AA1HSP90B1HSP90AB1MEN1CYP3A4
SCHEMBL1723554 0.76 HSP90AA1 (0.57) HSP90AA1HSP90B1HSP90AB1MEN1CYP3A4
Hydrochloric Acid SCHEMBL4053167 0.75 HSP90AA1 (0.56) HSP90AA1HSP90B1HSP90AB1MEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed